Pivotal phase 3 trial in cold agglutinin disease: sutimlimab can stop haemolysis Presented ByDr Alexander Röth, University of Duisburg-Essen, Germany TrialPhase 3, CARDINAL ConferenceASH 2019 5 March, 2020 22:36